Trial Profile
Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Responders After Induction Therapy in Metastatic Colorectal Cancer
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 28 Apr 2021 Status changed from recruiting to discontinued.
- 08 Jun 2019 Planned End Date changed from 31 Dec 2019 to 29 Jan 2021.
- 08 Jun 2019 Planned primary completion date changed from 31 Dec 2019 to 29 Jan 2021.